10-Q: Pineapple Express Cannabis Company Reports Q2 2024 Results, Revenue Growth Driven by Management Fees

Sentiment:

Quarterly Report


Pineapple Express Cannabis Company reports a revenue of $9,872 for the three months ended July 31, 2024, primarily from management fees, and a net income of $4,292.

Capital raiseThe company anticipates that it will be dependent, for the near future, on additional investment capital to fund operating expenses.The company intends to position itself so that it will be able to raise additional funds through the capital markets.There can be no assurance that we will be able to obtain financing on commercially acceptable terms, if at all.
Better than expectedThe company's revenue increased from $0 to $9,872 compared to the same period last year.The company's net income improved from a loss to a profit of $4,292 compared to the same period last year.Operating expenses decreased from $19,247 to $5,580 compared to the same period last year.

Summary

  • Pineapple Express Cannabis Company reported its financial results for the second quarter of 2024, ending July 31, 2024.
  • The company generated revenue of $9,872 for the quarter, a significant increase compared to no revenue in the same period last year.
  • This revenue was primarily driven by management fees from its cannabis retail ventures.
  • The company reported a net income of $4,292 for the quarter, a turnaround from a loss in the previous year.
  • Operating expenses were $5,580 for the quarter, down from $19,247 in the same period last year.
  • The company's cash balance is $0, and it has an accumulated deficit of $922,898.
  • The company is reliant on additional investment capital to fund operating expenses.
  • The company has a related party loan of $2,966,714 with a 1% interest rate.

Sentiment

Score: 5

Explanation: The document shows a mixed sentiment. While there is revenue growth and a net profit, the company's lack of cash, accumulated deficit, and dependence on future capital raises raise concerns. The going concern warning is also a significant negative.

Positives

  • The company generated revenue of $9,872, a significant increase from the same period last year.
  • The company achieved a net income of $4,292, a turnaround from a loss in the previous year.
  • Operating expenses decreased significantly year-over-year.
  • The company has a revenue share agreement with PCI, receiving half of the 10% management fee from several locations.
  • The company is actively involved in the cannabis retail sector through its investment in PCI.

Negatives

  • The company has a cash balance of $0.
  • The company has an accumulated deficit of $922,898.
  • The company is dependent on additional investment capital to fund operating expenses.
  • There is substantial doubt about the company's ability to continue as a going concern.
  • The company has a significant related party loan of $2,966,714.

Risks

  • The company's lack of cash and accumulated deficit raise substantial doubt about its ability to continue as a going concern.
  • The company is dependent on raising additional capital to fund operations.
  • There is no assurance that the company will be successful in raising additional funds.
  • The company may experience negative cash flows from operations as it expands its activities.
  • The company is subject to risks and uncertainties in the cannabis market.
  • The COVID-19 pandemic could negatively impact the company's business in the future.

Future Outlook

The company anticipates that it will be dependent, for the near future, on additional investment capital to fund operating expenses and intends to position itself to raise additional funds through the capital markets.

Management Comments

  • Management anticipates that the Company will be dependent, for the near future, on additional investment capital to fund operating expenses.
  • The Company intends to position itself so that it will be able to raise additional funds through the capital markets.

Industry Context

The company operates in the rapidly evolving cannabis industry, which is subject to regulatory changes and market fluctuations. The company's strategy of incubating early-stage ventures and managing retail cannabis operations aligns with the industry's growth trends.

Comparison to Industry Standards

  • It is difficult to compare Pineapple Express directly to industry standards due to its unique business model of combining incubation with retail operations.
  • Publicly traded cannabis companies such as Curaleaf, Trulieve, and Green Thumb Industries focus primarily on large-scale cultivation and retail, with significantly higher revenue and operating expenses.
  • Smaller cannabis companies often struggle with profitability and cash flow, similar to Pineapple Express's current situation.
  • The company's reliance on related party loans is not uncommon in the early stages of cannabis businesses, but it does highlight a potential risk.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
sole director and officerYulia LazaridouMatthew Feinstein2022-12-21Resignation

Legal Proceedings

  • The company is subject to various litigation and other claims in the normal course of business.
  • No amounts have been accrued in the financial statements with respect to any matters.

Related Party Transactions

  • The Company owes $2,966,714 to its related party equity method investee, Pineapple Consolidated, Inc. (PCI), as of April 30, 2024.
  • The company subleases office space from PCI at no charge.

Stakeholder Impact

  • Shareholders are impacted by the company's financial performance and its ability to raise capital.
  • Employees are impacted by the company's financial stability and its ability to continue operations.
  • Customers are impacted by the company's ability to provide cannabis retail services.
  • Suppliers are impacted by the company's ability to pay for goods and services.
  • Creditors are impacted by the company's ability to repay its debts.

Next Steps

  • The company intends to raise additional funds through the capital markets.
  • The company will continue to monitor the impact of COVID-19 on its business.
  • The company will continue to expand its footprint in the cannabis retail market.

Key Dates

DateDescription
2022-12-18Share Exchange Agreement with PCI Stockholders and Resignation Agreement with Yulia Lazaridou.
2022-12-21Yulia Lazaridou resigned as sole director and officer.
2022-12-30Company notified FINRA of intent to change corporate name and trading symbol.
2023-01-05Company filed Restated Articles of Incorporation with the State of Nevada.
2024-04-20Company executed a revenue share agreement with PCI.
2024-07-31End of the quarterly period for this report.
2024-08-09Promissory note with PCI reduced by $2,000,000.
2024-10-31Date of outstanding shares calculation.
2024-11-06Date of subsequent events analysis.
2024-11-12Date of report signature.

Keywords

cannabis, retail, management fees, revenue, net income, operating expenses, investment, incubator, related party loan, going concern

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.